Access cutting-edge sickle cell disease treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access sickle cell disease specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sickle cell disease treatment provided free
This is a multi-center multi-national rollover study to allow continued access to crizanlizumab for patients with sickle cell disease (SCD) who are on crizanlizumab treatment in a Novartis-sponsored study (parent study) and are benefiting from the treatment as judged by the investigator.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this sickle cell disease clinical trial in Birmingham, AL
If you're searching for sickle cell disease treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sickle cell disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.